Hypospadias and endocrine disruption: is there a connection?

L S Baskin, K Himes, T Colborn, L S Baskin, K Himes, T Colborn

Abstract

Hypospadias is one of the most common congenital anomalies in the United States, occurring in approximately 1 in 250 newborns or roughly 1 in 125 live male births. It is the result of arrested development of the urethra, foreskin, and ventral surface of the penis where the urethral opening may be anywhere along the shaft, within the scrotum, or in the perineum. The only treatment is surgery. Thus, prevention is imperative. To accomplish this, it is necessary to determine the etiology of hypospadias, the majority of which have been classified as idiopathic. In this paper we briefly describe the normal development of the male external genitalia and review the prevalence, etiology, risk factors, and epidemiology of hypospadias. The majority of hypospadias are believed to have a multifactorial etiology, although a small percentage do result from single gene mutations. Recent findings suggest that some hypospadias could be the result of disrupted gene expression. Discoveries about the antiandrogenic mechanisms of action of some contemporary-use chemicals have provided new knowledge about the organization and development of the urogenital system and may provide additional insight into the etiology of hypospadias and direction for prevention.

References

    1. Environ Health Perspect. 1995 Sep;103 Suppl 6:197-205
    1. Br J Urol. 1995 Dec;76 Suppl 3:23-30
    1. Environ Health Perspect. 1995 Oct;103 Suppl 7:137-9
    1. J Natl Cancer Inst. 1996 Jun 5;88(11):727-33
    1. Epidemiology. 1996 Jan;7(1):14-9
    1. J Reprod Fertil. 1996 Jan;106(1):63-6
    1. J Urol. 1996 Aug;156(2 Pt 2):828-31
    1. Arch Toxicol. 1996;70(7):451-6
    1. Environ Health Perspect. 1996 Apr;104(4):394-9
    1. Development. 1996 Sep;122(9):2687-96
    1. J Trop Pediatr. 1996 Aug;42(4):204-6
    1. Environ Health Perspect. 1996 Aug;104 Suppl 4:741-803
    1. Mol Cell Endocrinol. 1996 Oct 14;123(1):89-95
    1. Nat Genet. 1997 Feb;15(2):179-80
    1. Br J Urol. 1997 Jan;79(1):116-9
    1. Dev Dyn. 1997 Apr;208(4):454-65
    1. J Mol Med (Berl). 1997 Mar;75(3):198-207
    1. J Urol. 1997 May;157(5):1884-8
    1. Teratology. 1997 Feb;55(2):119-31
    1. Epidemiology. 1997 Sep;8(5):537-44
    1. J Pediatr. 1997 Sep;131(3):344-6
    1. J Pediatr. 1997 Sep;131(3):386-92
    1. Pediatrics. 1997 Nov;100(5):831-4
    1. Toxicol Ind Health. 1998 Jan-Apr;14(1-2):275-89
    1. Dev Biol. 1998 May 15;197(2):141-54
    1. Toxicol Appl Pharmacol. 1998 Jun;150(2):427-42
    1. Lancet. 1998 Aug 8;352(9126):423-7
    1. J Wildl Dis. 1998 Oct;34(4):792-6
    1. J Urol. 1998 Dec;160(6 Pt 1):2197-9
    1. Environ Health Perspect. 1998 Dec;106(12):793-6
    1. Horm Res. 1998;50(4):243-4
    1. Environ Health Perspect. 1999 Jan;107(1):75-81
    1. Toxicol Lett. 1998 Dec 28;102-103:331-5
    1. Environ Health Perspect. 1999 Apr;107(4):297-302
    1. Toxicol Ind Health. 1999 Jan-Mar;15(1-2):37-47
    1. Toxicol Ind Health. 1999 Jan-Mar;15(1-2):48-64
    1. Toxicol Ind Health. 1999 Jan-Mar;15(1-2):80-93
    1. Toxicol Ind Health. 1999 Jan-Mar;15(1-2):94-118
    1. Cell Tissue Res. 1999 Apr;296(1):3-17
    1. Dev Biol. 1999 May 1;209(1):28-39
    1. Arch Environ Contam Toxicol. 1999 May;36(4):447-55
    1. J Urol. 1999 Jun;161(6):1954-7
    1. J Zoo Wildl Med. 1999 Mar;30(1):141-4
    1. Cells Tissues Organs. 1999;164(3):125-30
    1. BJU Int. 2000 Jan;85(1):107-13
    1. Toxicol Sci. 2000 Feb;53(2):411-20
    1. Development. 2000 Jun;127(11):2471-9
    1. Environ Health Perspect. 2000 May;108(5):463-5
    1. J Clin Endocrinol Metab. 2000 Aug;85(8):2954-7
    1. Environ Health Perspect. 2000 Oct;108(10):979-82
    1. J Urol. 2001 Mar;165(3):934-6
    1. Am J Obstet Gynecol. 1968 Jul 15;101(6):830-3
    1. Arch Environ Health. 1969 Nov;19(5):628-32
    1. Mayo Clin Proc. 1974 Jan;49(1):52-8
    1. Pediatrics. 1976 Oct;58(4):505-7
    1. J Urol. 1977 Feb;117(2):220-2
    1. N Engl J Med. 1979 Jan 11;300(2):75-8
    1. Biochem Pharmacol. 1979 Jun 15;28(12):1865-77
    1. Biol Reprod. 1979 Mar;20(2):310-22
    1. J Urol. 1979 Jul;122(1):36-9
    1. J Urol. 1981 Mar;125(3):313-7
    1. Science. 1981 Mar 20;211(4488):1278-84
    1. Teratology. 1983 Jun;27(3):359-70
    1. Vet Rec. 1986 May 31;118(22):605-7
    1. Gen Pharmacol. 1987;18(2):165-9
    1. JAMA. 1988 Mar 18;259(11):1668-72
    1. Urol Clin North Am. 1988 May;15(2):223-36
    1. J Urol. 1988 Nov;140(5 Pt 2):1243-6
    1. J Med Genet. 1990 Sep;27(9):559-63
    1. Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):21-5
    1. Epidemiol Rev. 1990;12:29-40
    1. Dev Biol. 1991 Jul;146(1):106-16
    1. Contraception. 1991 Aug;44(2):173-82
    1. Genes Dev. 1991 Oct;5(10):1767-7
    1. Fertil Steril. 1991 Nov;56(5):918-22
    1. Am J Med Genet. 1992 Nov 1;44(4):482-4
    1. J Clin Endocrinol Metab. 1993 Jan;76(1):17-23
    1. Lancet. 1993 May 29;341(8857):1392-5
    1. Clin Genet. 1993 May;43(5):232-4
    1. Toxicol Appl Pharmacol. 1994 Jun;126(2):276-85
    1. Eur J Pediatr. 1994 May;153(5):317-21
    1. Obstet Gynecol. 1995 Jan;85(1):141-9
    1. Development. 1995 May;121(5):1373-85
    1. Nature. 1995 Jun 15;375(6532):581-5
    1. J Clin Endocrinol Metab. 1995 Sep;80(9):2697-9
    1. Br J Urol. 1995 Sep;76(3):384-8

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren